| abstract |
An oral pharmaceutical preparation containing an effective amount of NRC‑AN‑019, including its pharmaceutically acceptable salts and polymorphs thereof, dispersed in a polymer system in a subdivided final state to enhance oral bioavailability. It also relates to methods for the preparation of such compositions and the use of those compositions in the treatment of chronic myeloid leukemia and other tumors such as head and neck cancer, prostate cancer and the like. |